Lazard Asset Management LLC United Therapeutics Corp Transaction History

Lazard Asset Management LLC

  • $58.2 Billion
  • Q1 2025

A detailed history of Lazard Asset Management LLC transactions in United Therapeutics Corp stock. As of the latest transaction made, Lazard Asset Management LLC holds 29,439 shares of UTHR stock, worth $9.29 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
29,439
Previous 25,477 15.55%
Holding current value
$9.29 Million
Previous $8.99 Million 0.96%
% of portfolio
0.02%
Previous 0.01%

Shares

38 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 15, 2025
BUY
$304.42 - $380.78 $1.21 Million - $1.51 Million
3,962 Added 15.55%
29,439 $9.08 Million
Q4 2024

Feb 14, 2025
SELL
$348.66 - $410.0 $1.67 Million - $1.97 Million
-4,795 Reduced 15.84%
25,477 $8.99 Million
Q3 2024

Nov 14, 2024
SELL
$311.04 - $363.55 $23.5 Million - $27.4 Million
-75,422 Reduced 71.36%
30,272 $10.8 Million
Q2 2024

Aug 14, 2024
SELL
$228.26 - $319.04 $2.18 Million - $3.05 Million
-9,557 Reduced 8.29%
105,694 $33.7 Million
Q1 2024

May 14, 2024
SELL
$210.76 - $249.51 $17.2 Million - $20.4 Million
-81,822 Reduced 41.52%
115,251 $26.5 Million
Q4 2023

Feb 14, 2024
BUY
$214.88 - $256.94 $8.91 Million - $10.6 Million
41,445 Added 26.63%
197,073 $43.3 Million
Q3 2023

Nov 14, 2023
SELL
$211.82 - $248.24 $2 Million - $2.34 Million
-9,441 Reduced 5.72%
155,628 $35.2 Million
Q2 2023

Aug 14, 2023
BUY
$205.19 - $232.99 $5.58 Million - $6.34 Million
27,192 Added 19.72%
165,069 $36.4 Million
Q1 2023

May 15, 2023
BUY
$212.99 - $276.17 $4.77 Million - $6.19 Million
22,398 Added 19.4%
137,877 $30.9 Million
Q4 2022

Feb 14, 2023
SELL
$205.95 - $280.43 $10.1 Million - $13.8 Million
-49,058 Reduced 29.82%
115,479 $32.1 Million
Q3 2022

Nov 14, 2022
SELL
$203.3 - $244.17 $5.22 Million - $6.27 Million
-25,677 Reduced 13.5%
164,537 $34.5 Million
Q2 2022

Aug 09, 2022
SELL
$174.81 - $241.14 $7.31 Million - $10.1 Million
-41,813 Reduced 18.02%
190,214 $44.8 Million
Q1 2022

May 13, 2022
SELL
$166.16 - $213.96 $11.8 Million - $15.2 Million
-71,272 Reduced 23.5%
232,027 $41.6 Million
Q4 2021

Feb 09, 2022
SELL
$184.32 - $216.08 $2.62 Million - $3.07 Million
-14,218 Reduced 4.48%
303,299 $65.5 Million
Q3 2021

Nov 15, 2021
SELL
$179.86 - $214.88 $6.55 Million - $7.83 Million
-36,419 Reduced 10.29%
317,517 $58.6 Million
Q2 2021

Aug 12, 2021
BUY
$170.47 - $211.93 $8.46 Million - $10.5 Million
49,613 Added 16.3%
353,936 $63.5 Million
Q1 2021

May 14, 2021
BUY
$153.94 - $174.85 $9.01 Million - $10.2 Million
58,532 Added 23.81%
304,323 $50.9 Million
Q4 2020

Feb 11, 2021
BUY
$101.87 - $151.79 $3.15 Million - $4.7 Million
30,955 Added 14.41%
245,791 $37.3 Million
Q3 2020

Nov 13, 2020
BUY
$99.9 - $121.13 $333,865 - $404,816
3,342 Added 1.58%
214,836 $21.7 Million
Q2 2020

Aug 13, 2020
BUY
$92.74 - $125.82 $19.6 Million - $26.6 Million
211,494 New
211,494 $25.6 Million
Q2 2019

Aug 14, 2019
SELL
$76.06 - $120.81 $751,396 - $1.19 Million
-9,879 Closed
0 $0
Q1 2019

May 13, 2019
SELL
$107.15 - $126.84 $33,859 - $40,081
-316 Reduced 3.1%
9,879 $1.16 Million
Q3 2018

Nov 13, 2018
BUY
$113.81 - $129.46 $1.16 Million - $1.32 Million
10,195 New
10,195 $1.3 Million
Q1 2018

May 14, 2018
SELL
$107.21 - $151.94 $1,822 - $2,582
-17 Closed
0 $0
Q4 2017

Aug 28, 2019
SELL
$118.58 - $151.28 $3,557 - $4,538
-30 Reduced 63.83%
17 $2,000
Q4 2017

Feb 13, 2018
BUY
$118.58 - $151.28 $3,557 - $4,538
30 Added 176.47%
47 $6,000
Q3 2017

Aug 19, 2019
SELL
$114.6 - $136.81 $2,292 - $2,736
-20 Reduced 54.05%
17 $1,000
Q3 2017

Nov 13, 2017
BUY
$114.6 - $136.81 $2,177 - $2,599
19 Added 105.56%
37 $4,000
Q2 2017

Aug 19, 2019
SELL
N/A
-37,443 Reduced 99.95%
18 $2,000
Q1 2017

Aug 13, 2019
SELL
N/A
-56,018 Reduced 59.93%
37,461 $5.07 Million
Q4 2016

Jul 30, 2019
BUY
N/A
6,298 Added 7.22%
93,479 $13.4 Million
Q3 2016

Aug 07, 2019
BUY
N/A
3,700 Added 4.43%
87,181 $10.3 Million
Q2 2016

Jul 29, 2019
SELL
N/A
-159,607 Reduced 65.66%
83,481 $8.84 Million
Q1 2016

Jul 25, 2019
BUY
N/A
48,537 Added 24.95%
243,088 $27.1 Million
Q4 2015

Jul 24, 2019
BUY
N/A
49,334 Added 33.97%
194,551 $30.5 Million
Q3 2015

Jul 15, 2019
SELL
N/A
-124,977 Reduced 46.25%
145,217 $19.1 Million
Q2 2015

Jul 08, 2019
BUY
N/A
158,823 Added 142.61%
270,194 $47 Million
Q4 2014

Aug 29, 2019
BUY
N/A
111,371
111,371 $14.4 Million

Others Institutions Holding UTHR

# of Institutions
733
Shares Held
43.6M
Call Options Held
124K
Put Options Held
122K
View Full List

About UNITED THERAPEUTICS Corp

UTHR Quotes by TradingView
  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $14.4B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Lazard Asset Management LLC Portfolio

Follow Lazard Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lazard Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lazard Asset Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email